Which Projects Is Intel (INTC) Ramping Spending On And Why? - Nomura
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Nomura Securities analyst, Romit Shah, reiterated his Buy rating on shares of Intel (NASDAQ: INTC) and reiterated his price target of $40 despite voicing an increasing concern that Intel's increase in OpEx guidance is not just sandbagging for the incoming CFO but spending to address unexpected concerns.
Management implicitly raised operating expense guidance for 2017 by several percentage points relative to their forecast in April. The revised outlook is especially glaring when you consider that since April, consensus revenues for 2016 are $2b higher and the company sold McAfee, both of which are margin enhancing developments.
It is possible that Intel is just wanting to set conservative expectations for incoming CFO Bob Swan. This is the prevailing view among investors we spoke to. However, seeing the market’s reaction post earnings, it is likely more complicated. In addition, management talked about “reinvestment” several times during the earnings call. And that point was emphasized in the analyst's callback with the company. Amid weakness in the Datacenter Group, the analyst believes investors should be asking, “Which projects is Intel spending on that they didn't contemplate back in April? And why?”
Shares of Intel closed at $35.15 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Drexel Hamilton Raises Price Target on Workday (WDAY) Following 3Q Beat
- Dougherty & Co Starts CardioNet (BEAT) at Buy
- Jefferies Raises Price Target on Zumiez, Inc. (ZUMZ) to $23 Following 3Q
Create E-mail Alert Related CategoriesAnalyst Comments
Related EntitiesNomura, McAfee Intel Merger, Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!